$320.11
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
West Pharmaceutical Servs reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of West Pharmaceutical Servs using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
WST | West Pharmaceutical Servs | $2.11 | $1.74 | — | — | $753.80M | $729.35M | — | — | 07/25/2024 | Get Alert |
WST | West Pharmaceutical Servs | $1.98 | $1.26 | $1.56 | 23.81% | $716.60M | $670.30M | $695.40M | 3.74% | 04/25/2024 | Get Alert |
WST | West Pharmaceutical Servs | $1.77 | $1.78 | $1.83 | 2.81% | $708.70M | $739.47M | $732.00M | -1.01% | 02/15/2024 | Get Alert |
WST | West Pharmaceutical Servs | $2.03 | $1.86 | $2.16 | 16.13% | $686.90M | $750.31M | $747.40M | -0.39% | 10/26/2023 | Get Alert |
WST | West Pharmaceutical Servs | $2.47 | $1.93 | $2.11 | 9.33% | $771.30M | $756.53M | $753.80M | -0.36% | 07/27/2023 | Get Alert |
WST | West Pharmaceutical Servs | $2.30 | $1.65 | $1.98 | 20.00% | $720.00M | $693.82M | $716.60M | 3.28% | 04/27/2023 | Get Alert |
WST | West Pharmaceutical Servs | $2.04 | $1.38 | $1.77 | 28.26% | $730.80M | $657.17M | $708.70M | 7.84% | 02/16/2023 | Get Alert |
WST | West Pharmaceutical Servs | $2.06 | $2.12 | $2.03 | -4.25% | $706.50M | $731.61M | $686.90M | -6.11% | 10/27/2022 | Get Alert |
WST | West Pharmaceutical Servs | $2.46 | $2.21 | $2.47 | 11.76% | $723.60M | $755.57M | $771.30M | 2.08% | 07/28/2022 | Get Alert |
WST | West Pharmaceutical Servs | $2.05 | $2.12 | $2.30 | 8.49% | $670.70M | $720.92M | $720.00M | -0.13% | 04/28/2022 | Get Alert |
WST | West Pharmaceutical Servs | $1.34 | $1.91 | $2.04 | 6.81% | $580.20M | $710.20M | $730.80M | 2.90% | 02/17/2022 | Get Alert |
WST | West Pharmaceutical Servs | $1.15 | $1.80 | $2.06 | 14.44% | $548.00M | $687.09M | $706.50M | 2.82% | 10/28/2021 | Get Alert |
WST | West Pharmaceutical Servs | $1.25 | $1.74 | $2.46 | 41.38% | $527.20M | $669.38M | $723.60M | 8.10% | 07/29/2021 | Get Alert |
WST | West Pharmaceutical Servs | $1.01 | $1.43 | $2.05 | 43.36% | $491.50M | $611.39M | $670.70M | 9.70% | 04/29/2021 | Get Alert |
WST | West Pharmaceutical Servs | $0.82 | $1.12 | $1.34 | 19.64% | $470.60M | $543.67M | $580.20M | 6.72% | 02/18/2021 | Get Alert |
WST | West Pharmaceutical Servs | $0.79 | $0.99 | $1.15 | 16.16% | $456.10M | $510.14M | $548.00M | 7.42% | 10/22/2020 | Get Alert |
WST | West Pharmaceutical Servs | $0.89 | $0.88 | $1.25 | 42.05% | $469.70M | $490.58M | $527.20M | 7.46% | 07/23/2020 | Get Alert |
WST | West Pharmaceutical Servs | $0.74 | $0.82 | $1.01 | 23.17% | $443.50M | $466.79M | $491.50M | 5.29% | 04/23/2020 | Get Alert |
WST | West Pharmaceutical Servs | $0.73 | $0.72 | $0.82 | 13.89% | $422.50M | $451.53M | $470.60M | 4.22% | 02/13/2020 | Get Alert |
WST | West Pharmaceutical Servs | $0.76 | $0.71 | $0.79 | 11.27% | $431.70M | $450.94M | $456.10M | 1.14% | 10/24/2019 | Get Alert |
WST | West Pharmaceutical Servs | $0.70 | $0.72 | $0.89 | 23.61% | $447.50M | $460.40M | $469.70M | 2.02% | 07/25/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-04-25 | $1.56 | $1.26 | 23.8 % |
Dec 2023 | 2024-02-15 | $1.83 | $1.78 | 2.81 % |
Sep 2023 | 2023-10-26 | $2.16 | $1.86 | 16.1 % |
Jun 2023 | 2023-07-27 | $2.11 | $1.93 | 9.33 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-04-25 | $695.40M | $670.30M | 3.74 % |
Dec 2023 | 2024-02-15 | $732.00M | $739.47M | -1.01 % |
Sep 2023 | 2023-10-26 | $747.40M | $750.31M | -0.39 % |
Jun 2023 | 2023-07-27 | $753.80M | $756.53M | -0.36 % |
West Pharmaceutical Servs (WST) is scheduled to report earnings on July 25, 2024. The last reported earnings were for reported on April 25, 2024 for Q1.
The Actual EPS was $1.56, which beat the estimate of $1.26.
The Actual Revenue was $695.4M, which beat the estimate of $670.3M.
Browse earnings estimates, EPS, and revenue on all stocks.